12 results on '"Masuda, Haruchika"'
Search Results
2. Vascular Regeneration Therapy: Endothelial Progenitor Cells for Ischemic Diseases
- Author
-
Ii, Masaaki, Kawamoto, Atsuhiko, Masuda, Haruchika, Asahara, Takayuki, and Steinhoff, Gustav, editor
- Published
- 2016
- Full Text
- View/download PDF
3. Transplantation of ex vivo Expanded Endothelial Progenitor Cells for Therapeutic Neovascularization
- Author
-
Kalka, Christoph, Masuda, Haruchika, Takahashi, Tomono, Kalka-Moll, Wiltrud M., Silver, Marcy, Kearney, Marianne, Li, Tong, Isner, Jeffrey M., and Asahara, Takayuki
- Published
- 2000
4. Endothelial progenitor cells for postnatal vasculogenesis
- Author
-
Eguchi, Masamichi, Masuda, Haruchika, and Asahara, Takayuki
- Published
- 2007
- Full Text
- View/download PDF
5. 血管内皮前駆細胞の血管新生作用に対する水溶性スタチン(プラバスタチン)の影響
- Author
-
IWAMI, Yo, MASUDA, Haruchika, TSURUMI, Yukio, KASANUKI, Hiroshi, and ASAHARA, Takayuki
- Subjects
pravastatin ,angiogenesis ,eNOS ,EPC ,vasculogenesis - Abstract
脂溶性HMG-CoAリダクターゼ・インヒビター(脂溶性スタチン)による血管内皮前駆細胞(EPC)動員,治療的血管形成作用改善効果は多数の報告がされている.しかしながら水溶性スタチン(プラバスタチン)のEPCに対する作用は充分に解明されていない.本研究により,水溶性スタチンがEPC内に取り込まれ,細胞内シグナルを刺激することでEPC動態に作用することを明らかとする.^C標識プラバスタチンにより,HepG2細胞を対照群としてEPC内へのプラバスタチン取り込みを測定した結果,EPC群は有意にプラバスタチンを細胞内に取り込んだ(*29.15±2.80vs7.82±0.47count/min/mg protein,^*p, Previous studies have demonstrated that hydrophobic hydroxymethyl glutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) mobilize circulating endothelial progenitor cells (EPCs), and contribute to therapeutic vasculogenesis. However, the effects of hydrophilic statin (pravastatin) on EPC kinetics remain to be investigated. Here, we investigated whether pravastatin stimulates EPC kinetics via intracellular signal transduction following its uptake by EPCs. Pravastatin uptake by cultured EPCs was measured by 14C-radio labeled molecules, and was compared with that by HepG2 cells as a negative control (^*29.15 ± 2.80 vs 7.82 ± 0.47 count/min/mg protein, ^*p
- Published
- 2007
6. Batroxobin accelerated tissue repair via neutrophil extracellular trap regulation and defibrinogenation in a murine ischemic hindlimb model.
- Author
-
Masuda, Haruchika, Sato, Atsuko, Shizuno, Tomoko, Yokoyama, Keiko, Suzuki, Yusuke, Tokunaga, Masayoshi, and Asahara, Takayuki
- Subjects
- *
HYPOXIA-inducible factor 1 , *SKELETAL muscle , *PLACENTAL growth factor , *DEVELOPMENTAL biology , *CYTOLOGY , *INTRAPERITONEAL injections - Abstract
Batroxobin, isolated from Bothrops moojeni, is a defibrinogenating agent used as a thrombin-like serine protease against fibrinogen for improving microcirculation. Here, we investigated whether, and if so, how batroxobin restores ischemic tissue injury in terms of anti-inflammatory effects. In an in vitro flow cytometry assay for human neutrophil extracellular traps (NETs), batroxobin (DF-521; Defibrase) inhibited human NETs induced by tumor necrosis factor-α (TNF-α) in the presence of human fibrinogen. Next, the effect of batroxobin was investigated by immunohistochemistry of the anterior tibial muscle (ATM) in an ischemic hindlimb model using C57BL/6J mice intraperitoneally injected with DF-521 versus the saline control. NETs and fibrinogen deposition in the ischemic ATM decreased in DF-521-treated mice on day 2 after ischemia. Meanwhile, reverse transcription-quantitative PCR assay of the ischemic ATM unveiled continuous downregulation in the expression of the genes; Tnf-α and nitric oxide synthase2 (Nos2) with hypoxia-inducible factor-1α (Hif-1α) and vascular endothelial growth factor-a (Vegf-a) from day 3 to day 7, but the upregulation of arginase-1 (Arg-1) and placental growth factor (Plgf) with myogenin (Myog) on day 7. Daily intraperitoneal DF-521 injection for the initial 7 days into mice with ischemic hindlimbs promoted angiogenesis and arteriogenesis on day 14. Moreover, DF-521 injection accelerated myofiber maturation after day 14. Laser doppler imaging analysis revealed that blood perfusion in DF-521-injected mice significantly improved on day 14 versus the saline control. Thus, DF-521 improves microcirculation by protecting NETs with tissue defibrinogenation, thereby protecting against severe ischemic tissue injury and accelerating vascular and skeletal muscular regeneration. To our knowledge, batroxobin might be the first clinically applicable NET inhibitor against ischemic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
7. Regeneration-associated cell transplantation contributes to tissue recovery in mice with acute ischemic stroke.
- Author
-
Nakayama, Taira, Nagata, Eiichiro, Masuda, Haruchika, Asahara, Takayuki, and Takizawa, Shunya
- Subjects
CELL transplantation ,STROKE ,REGENERATION (Biology) ,VASCULAR endothelial growth factors ,LABORATORY mice - Abstract
Various cell-based therapeutic strategies have been investigated for vascular and tissue regeneration after ischemic stroke. We have developed a novel cell population, called regeneration-associated cells (RACs), by quality- and quantity-controlled culture of unfractionated mononuclear cells. RACs were trans-arterially injected into 10-week-old syngeneic male mice at 1, 3, 5 or 7 days after permanent middle cerebral artery occlusion (MCAO) to determine the optimal timing for administration in terms of outcome at day 21. Next, we examined the effects of RACs injection at day 1 after MCAO on neurological deficits, infarct volume, and mediators of vascular regeneration and anti-inflammation at days 7 and 21. Infarct volume at day 21 was significantly reduced by transplantation of RACs at day 1 or 3. RACs injected at day 1 reduced the infarct volume at day 7 and 21. Angiogenesis and anti-inflammatory mediators, VEGF and IL-10, were increased at day 7, and VEGF was still upregulated at day 21. We also observed significantly enhanced ink perfusion in vivo, tube formation in vitro, and definitive endothelial progenitor cell colonies in colony assay. These results suggest that RAC transplantation in MCAO models promoted significant recovery of neural tissues through intensified anti-inflammatory and angiogenic effects. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
8. Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis.
- Author
-
Salybekov, Amankeldi A., Kawaguchi, Akira T., Masuda, Haruchika, Vorateera, Kosit, Okada, Chisa, and Asahara, Takayuki
- Subjects
MYOCARDIAL infarction ,NEOVASCULARIZATION ,ANTI-inflammatory agents ,THROMBOPOIETIN ,NEUTROPHILS - Abstract
Background: Considering the impaired function of regenerative cells in myocardial infarction (MI) patients with comorbidities and associated risk factors, cell therapy to enhance the regenerative microenvironment was designed using regeneration-associated cells (RACs), including endothelial progenitor cells (EPCs) and anti-inflammatory cells. Methods: RACs were prepared by quality and quantity control culture of blood mononuclear cells (QQMNCs). Peripheral blood mononuclear cells (PBMNCs) were isolated from Lewis rats and conditioned for 5 days using a medium containing stem cell factors, thrombopoietin, Flt-3 ligand, vascular endothelial growth factor, and interleukin-6 to generate QQMNCs. Results: A 5.3-fold increase in the definitive colony-forming EPCs and vasculogenic EPCs was observed, in comparison to naïve PBMNCs. QQMNCs were enriched with EPCs (28.9-fold, P<0.0019) and M2 macrophages (160.3-fold, P<0.0002). Genes involved in angiogenesis (angpt1, angpt2, and vegfb), stem/progenitors (c-kit and sca-1), and anti-inflammation (arg-1, erg-2, tgfb, and foxp3) were upregulated in QQMNCs. For in vivo experiments, cells were administered into syngeneic rat models of MI. QQMNC-transplanted group (QQ-Tx) preserved cardiac function and fraction shortening 28 days post-MI in comparison with PBMNCs-transplanted (PB-Tx) (P<0.0001) and Control (P<0.0008) groups. QQ-Tx showed enhanced angiogenesis and reduced interstitial left ventricular fibrosis, along with a decrease in neutrophils and an increase in M2 macrophages in the acute phase of MI. Cell tracing studies revealed that intravenously administered QQMNCs preferentially homed to ischemic tissues via blood circulation. QQ-Tx showed markedly upregulated early cardiac transcriptional cofactors (Nkx2-5, 29.8-fold, and Gata-4, 5.2-fold) as well as c-kit (4.5-fold) while these markers were downregulated in PB-Tx. In QQ-Tx animals, de novo blood vessels formed a “Biological Bypass”, observed macroscopically and microscopically, while PB-Tx and Control-Tx groups showed severe fibrotic adhesion to the surrounding tissues, but no epicardial blood vessels. Conclusion: QQMNCs conferred potent angiogenic and anti-inflammatory properties to the regenerative microenvironment, enhancing myocardiogenesis and functional recovery of rat MI hearts. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. Jagged-1 Signaling in the Bone Marrow Microenvironment Promotes Endothelial Progenitor Cell Expansion and Commitment of CD133+ Human Cord Blood Cells for Postnatal Vasculogenesis.
- Author
-
Ishige-Wada, Mika, Kwon, Sang-Mo, Eguchi, Masamichi, Hozumi, Katsuto, Iwaguro, Hideki, Matsumoto, Taro, Fukuda, Noboru, Mugishima, Hideo, Masuda, Haruchika, and Asahara, Takayuki
- Subjects
NOTCH signaling pathway ,NEOVASCULARIZATION ,BONE marrow examination ,PROGENITOR cells ,CORD blood - Abstract
Notch signaling is involved in cell fate decisions during murine vascular development and hematopoiesis in the microenvironment of bone marrow. To investigate the close relationship between hematopoietic stem cells and human endothelial progenitor cells (EPCs) in the bone marrow niche, we examined the effects of Notch signals [Jagged-1 and Delta-like ligand (Dll)-1] on the proliferation and differentiation of human CD133
+ cell-derived EPCs. We established stromal systems using HESS-5 murine bone marrow cells transfected with human Jagged-1 (hJagged-1) or human Dll-1 (hDll-1). CD133+ cord blood cells were co-cultured with the stromal cells for 7 days, and then their proliferation, differentiation, and EPC colony formation was evaluated. We found that hJagged-1 induced the proliferation and differentiation of CD133+ cord blood EPCs. In contrast, hDll-1 had little effect. CD133+ cells stimulated by hJagged-1 differentiated into CD31+ /KDR+ cells, expressed vascular endothelial growth factor-A, and showed enhanced EPC colony formation compared with CD133+ cells stimulated by hDll-1. To evaluate the angiogenic properties of hJagged-1- and hDll-1-stimulated EPCs in vivo, we transplanted these cells into the ischemic hindlimbs of nude mice. Transplantation of EPCs stimulated by hJagged-1, but not hDll-1, increased regional blood flow and capillary density in ischemic hindlimb muscles. This is the first study to show that human Notch signaling influences EPC proliferation and differentiation in the bone marrow microenvironment. Human Jagged-1 induced the proliferation and differentiation of CD133+ cord blood progenitors compared with hDll-1. Thus, hJagged-1 signaling in the bone marrow niche may be used to expand EPCs for therapeutic angiogenesis. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
10. Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis.
- Author
-
Alaiti, Mohamad Amer, Ishikawa, Masakazu, Masuda, Haruchika, Simon, Daniel I., Jain, Mukesh K., Asahara, Takayuki, and Costa, Marco A.
- Subjects
VASCULAR endothelial growth factor antagonists ,GENETIC regulation ,CD3 antigen ,CELL-mediated cytotoxicity ,NEOVASCULARIZATION ,HEMATOPOIETIC stem cells ,THROMBOPOIETIN - Abstract
Ex vivo culture has been proposed as a means to augment and repair autologous cells in patients with chronic diseases, but the mechanisms governing improvement in cell function are not well understood. Although micro RNAs (miRs) are increasingly appreciated as key regulators of cellular function, a role for these factors in CD34+ cell-mediated angiogenesis has not been elucidated. Vascular endothelial growth factor ( VEGF) was previously shown to induce expression of certain miRs associated with angiogenesis in endothelial cells and promote survival and number of vascular colony forming units of haematopoietic stem cells ( HSCs). We sought to evaluate the role of VEGF in expansion and angiogenic function of CD34+ cells and to identify specific miRs associated with angiogenic properties of expanded cells. Umbilical cord blood CD34+ cells were effectively expanded (18- to 22-fold) in culture medium containing stem cell factor ( SCF), Flt-3 ligand (Flt-3), thrombopoietin ( TPO) and interleukin-6 ( IL-6) with (post EX/+ VEGF) and without VEGF (post EX/no VEGF). Tube formation in matrigel assay and tissue perfusion/capillary density in mice ischaemic hindlimb were significantly improved by post EX/+ VEGF cells compared with fresh CD34+ and post EX/no VEGF cells. MiR-210 expression was significantly up-regulated in post EX/+ VEGF cells. MiR-210 inhibitor abrogated and 210 mimic recapitulated the pro-angiogenic effects by treatment of post EX/+ VEGF and post EX/no VEGF cells respectively. Collectively, these observations highlight a critical role for VEGF in enhancing the angiogenic property of expanded cells, and identify miR-210 as a potential therapeutic target to enhance CD34+ stem cell function for the treatment of ischaemic vascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
11. Ex-vivo expanded human blood-derived CD133+ cells promote repair of injured spinal cord.
- Author
-
Kamei, Naosuke, Kwon, Sang-Mo, Alev, Cantas, Nakanishi, Kazuyoshi, Yamada, Kiyotaka, Masuda, Haruchika, Ishikawa, Masakazu, Kawamoto, Atsuhiko, Ochi, Mitsuo, and Asahara, Takayuki
- Subjects
- *
THERAPEUTICS , *SPINAL cord injuries , *CELL transplantation , *REGENERATION (Biology) , *LABORATORY mice , *PROGENITOR cells , *CELL populations - Abstract
Abstract: Human blood-derived CD133+ cell populations, which are believed to represent a hematopoietic/endothelial progenitor fraction, have the ability to promote the repair of injured spinal cord in animal models. However, the mechanisms by which CD133+ cell transplantation promotes spinal cord regeneration remain to be clarified. Another possible hurdle on the way to clinical applicability of these cells is their scarce representation in the overall population of mononuclear cells. We therefore analyzed and compared ex-vivo expanded human cord blood derived CD133+ cells with freshly isolated CD133+ cells as well as corresponding CD133− control mononuclear cells in respect to their ability to promote spinal cord repair using in vitro assays and cell transplantation into a mouse spinal cord injury model. In vitro, expanded cells as well as fresh CD133+ cells formed endothelial progenitor cell (EPC) colonies, whereas CD133− cells formed no EPC colonies. In vivo, the administration of fresh CD133+ and expanded cells enhanced angiogenesis, astrogliosis, axon growth and functional recovery after injury. In contrast, the administration of CD133− cells failed to promote axon growth and functional recovery, but moderately enhanced angiogenesis and astrogliosis. In addition, high-dose administration of expanded cells was highly effective in the induction of regenerative processes at the injured spinal cord. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
12. Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization
- Author
-
Kwon, Sang-Mo, Lee, Yun-Kyung, Yokoyama, Ayumi, Jung, Seok-Yun, Masuda, Haruchika, Kawamoto, Atsuhiko, Lee, You Mie, and Asahara, Takayuki
- Subjects
- *
BONE marrow , *HEMATOPOIETIC stem cells , *NEOVASCULARIZATION , *ENDOTHELIUM , *MORPHOLOGY , *REVERSE transcriptase polymerase chain reaction , *VASCULAR endothelial growth factors , *CELL lines - Abstract
Abstract: Although endothelial progenitor cells (EPCs) differentiate from minor populations of stem cells in bone marrow (BM), the differential role of hematopoietic stem cell (HSC) subpopulations in EPC development is largely unclear. Morphological characterization of EPC colonies has revealed that c-kit+/Sca-1+/lineage (Lin)-(KSL) cells mainly develop small EPC-colony forming units (CFUs) not large EPC-CFUs. In contrast, c-kit+/Sca-1−/Lin− (KL) cells develop large EPC-CFUs not small EPC-CFUs. Neither c-kit-/Sca-1+/Lin− (SL) cells nor c-kit−/Sca-1−/Lin− (L) cells develop EPC-CFUs to an appreciable extent. Hindlimb ischemia enhances formation of large EPC-CFUs from all HSC subpopulations, suggesting an important role for ischemia in functional EPC development. Real time RT-PCR analysis shows that KSL, KL and SL cells but not L cells express various factors at high levels, maintaining a BM-EPC pool. In hindlimb ischemia, transplanted KSL, KL and SL cells efficiently differentiate into endothelial lineage cells in situ and augment capillary density. The percentage of Ki-67+ cycling cells among transplanted cells in ischemic tissue was also greater for KSL, KL and SL cells than L cells. Moreover, the frequency of VEGF- or SDF-1-expressing cells was higher transplanted KSL, KL or SL cells than L cells. Thus, KSL, KL and SL cells are not different in their angiogenic competence under ischemic conditions. In conclusion, although KSL cells are clearly the most potent contributors to EPC development, KL and SL cells may also contribute to neovascularization via both autocrine and paracrine mechanisms in response to ischemic signals. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.